Stock A258540 SL THERAPEUTICS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

News SL Therapeutics, Inc.

Equities

A258540

KR7258540004

End-of-day quote Korea S.E.
Other stock markets
 18:00:00 2024-06-13 EDT 		5-day change 1st Jan Change
1,517 KRW -14.97% Intraday chart for SL Therapeutics, Inc. -22.96% +157.56%
2022 StemLab Inc. announced that it has received KRW 1.5000006 billion in funding CI
2022 StemLab Inc. announced that it expects to receive KRW 1.5000006 billion in funding CI

Summary

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
In volo con Leonardo: the new work orientation pathway of the STEMLab project
AQ
StemLab Inc. announced that it has received KRW 1.5000006 billion in funding
CI
StemLab Inc. announced that it expects to receive KRW 1.5000006 billion in funding
CI
StemLab Inc. announced that it has received KRW 4 billion in funding
CI
StemLab Inc. announced that it expects to receive KRW 4 billion in funding
CI
StemLab Inc. announced that it has received KRW 5 billion in funding from DAYLI Partners Co., Ltd., IBK Capital Corporation, Blueotus Co., Ltd., DB Asset Management Co., Ltd.
CI
StemLab Inc. announced that it expects to receive KRW 5 billion in funding from DAYLI Partners Co., Ltd., IBK Capital Corporation, Blueotus Co., Ltd., DB Asset Management Co., Ltd. and another investor
CI
StemLab Inc. announced that it has received KRW 1.5 billion in funding
CI
StemLab Inc. announced that it expects to receive KRW 1.5 billion in funding
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. A258540 Stock
  4. News SL Therapeutics, Inc.